Literature DB >> 26277594

Continuing IgG replacement therapy for hypogammaglobulinemia after rituximab--for how long?

Sara Barmettler1, Christina Price2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26277594     DOI： 10.1016/j.jaci.2015.06.035

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  14 in total

1.  Immunoglobulin serum levels in rituximab-treated patients with steroid-dependent nephrotic syndrome.

Authors:  Cyrielle Parmentier; Jean-Daniel Delbet; Stéphane Decramer; Olivia Boyer; Julien Hogan; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2019-11-08       Impact factor: 3.714

Review 2.  Immune deficiency in chronic rhinosinusitis: screening and treatment.

Authors:  Sergio E Chiarella; Leslie C Grammer
Journal:  Expert Rev Clin Immunol       Date:  2016-08-18       Impact factor: 4.473

Review 3.  Unintended Immunological Consequences of Biologic Therapy.

Authors:  Sarah E Henrickson; Melanie A Ruffner; Mildred Kwan
Journal:  Curr Allergy Asthma Rep       Date:  2016-06       Impact factor: 4.806

4.  [Immunodeficiency in chronic rhinosinusitis : An important and often underestimated cause].

Authors:  L Klimek; A Chaker; C Matthias; A Sperl; P Gevaert; P Hellings; B Wollenberg; M Koennecke; J Hagemann; J Eckrich; S Becker
Journal:  HNO       Date:  2019-09       Impact factor: 1.284

Review 5.  Established and Emerging Immunological Complications of Biological Therapeutics in Multiple Sclerosis.

Authors:  Babak Soleimani; Katy Murray; David Hunt
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.606

Review 6.  Advances in clinical immunology in 2015.

Authors:  Javier Chinen; Luigi D Notarangelo; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2016-12       Impact factor: 10.793

Review 7.  Rituximab and eculizumab when treating nonmalignant hematologic disorders: infection risk, immunization recommendations, and antimicrobial prophylaxis needs.

Authors:  Elissa R Engel; Jolan E Walter
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

8.  EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System.

Authors:  Jacques J M van Dongen; Mirjam van der Burg; Tomas Kalina; Martin Perez-Andres; Ester Mejstrikova; Marcela Vlkova; Eduardo Lopez-Granados; Marjolein Wentink; Anne-Kathrin Kienzler; Jan Philippé; Ana E Sousa; Menno C van Zelm; Elena Blanco; Alberto Orfao
Journal:  Front Immunol       Date:  2019-06-13       Impact factor: 7.561

9.  Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia.

Authors:  Sara Barmettler; Mei-Sing Ong; Jocelyn R Farmer; Hyon Choi; Jolan Walter
Journal:  JAMA Netw Open       Date:  2018-11-02

10.  A Race Against Time-Changing the Natural History of CRIM Negative Infantile Pompe Disease.

Authors:  Punita Gupta; Brian J Shayota; Ankit K Desai; Fuad Kiblawi; Dorothy Myridakis; John Messina; Peter Tah; Lorien Tambini-King; Priya S Kishnani
Journal:  Front Immunol       Date:  2020-09-04       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.